High drug loaded injectable microparticle compositions and...

Details High drug loaded injectable microparticle compositions and... High drug loaded injectable microparticle compositions and...

2006-05-09

2006-05-09

Kishore, Gollamudi S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S489000, C424S490000, C424S501000, C264S004100, C264S004300, C264S004600

Reexamination Certificate

active

07041320

ABSTRACT:
Methods and compositions to induce opioid drug independence in opioid drug dependent individuals comprising administering opioid agonists and/or antagonists encapsulated in biodegradable polymer microspheres in a dosage formulation.

REFERENCES:
patent: 3523906 (1970-08-01), Hova et al.
patent: 3691090 (1972-09-01), Kitajima et al.
patent: 3737337 (1973-06-01), Wuppertal-Elberfeld et al.
patent: 3891570 (1975-06-01), Fukushima et al.
patent: 3960757 (1976-06-01), Morishita et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4499096 (1985-02-01), Lotsof
patent: 4530840 (1985-07-01), Tice et al.
patent: 4542025 (1985-09-01), Tice et al.
patent: 4568559 (1986-02-01), Nuwayser et al.
patent: 4582835 (1986-04-01), Lewis et al.
patent: 4588580 (1986-05-01), Gale et al.
patent: 4623588 (1986-11-01), Nuwayser et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4895848 (1990-01-01), Traber et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4919916 (1990-04-01), Golwyn
patent: 4931277 (1990-06-01), Fontaine et al.
patent: 4935428 (1990-06-01), Lewis
patent: 4935429 (1990-06-01), Dackis et al.
patent: 4942182 (1990-07-01), Weiss et al.
patent: 5023081 (1991-06-01), Trau et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5100916 (1992-03-01), Johansson et al.
patent: 5124340 (1992-06-01), Jaffe et al.
patent: 5140032 (1992-08-01), Radecki
patent: 5149538 (1992-09-01), Granger et al.
patent: 5223497 (1993-06-01), Gawin et al.
patent: 5240711 (1993-08-01), Hille et al.
patent: 5256669 (1993-10-01), Askanazi et al.
patent: 5272149 (1993-12-01), Stalling
patent: 5298622 (1994-03-01), Portoghese et al.
patent: 5407609 (1995-04-01), Tice et al.
patent: 5500227 (1996-03-01), Oshlack et al.
patent: 5648097 (1997-07-01), Nuwayser
patent: 5993855 (1999-11-01), Yoshimoto et al.
patent: 6306425 (2001-10-01), Tice et al.
patent: 6495155 (2002-12-01), Tice et al.
Nuwayser et al., “Microencapsulation of Contraceptive Steroids,” Proc. 11th Inter. Symp. Control. Rel. Bioactive Mater., pp. 71-72 (1984).
Amory et al., “Testosterone Release from a Subcutaneous, Biodegradable Microcapsule Formulation (Viatrel) in Hypogonadal Men,”J. Andrology, 23(1):84-91 (2002).
Comer et al., “Depot naltrexone: long-lasting antagonism of the effects of heroin in humans,”Psychopharmacology, 159:351-360 (2002).
Kranzler et al., “Sustained-Release naltrexone for Alcoholism Treatment: A Preliminary Study,”Alcoholism: Clin. and Exp. Res., 22(5):1074-1079 (1998).
Leary, “Drug for Heroin Addiction Is Being marketed for Treatment of Alcoholism,”New York Times, p. A18, Jan. 18, 1995.
Nath et al., “Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations,”J. Clin. Pharm., 39:619-623 (1999).
Nuwayser et al., “Microencapsulation of Contraceptive Steroids,”Proc. 11thInter. Symp. Control. Rel. Bioactive Mater., pp. 71-72 (1984).
Nuwayser and DeRoo, “Microencapsulation with Microfluidized Beds,”Proc. 14thInter. Symp. Control. Rel. Bioactive Mater., 2 pages (1987).
Nuwayser et al., “Sustained Release Injectable Naltrexone Microcapsules,”Proc. Inter. Symp. Control. Rel. Bioactive Mater., 15:201-202 (1988).
Nuwayser et al., “Sustained Release Injectable Methadone Microcapsules,”Proc. Inter. Symp. Control. Rel. Bioactive Mater., 16:83-84 (1989).
Nuwayser et al., “Sustained Release Injectable Naltrexone Microcapsules,”Proc. 52ndAnn. Sci. Meeting, L. Harris, ed. NIDA Research Monograph 105, 532 (1991).
Nuwayser and Blaskovich, “In Vivo Studies of a One Month Injection for Buprenorphine,”Proc. Inter. Symp. Control. Rel. Bioactive Mater., 19:168-169 (1992).
Petry et al., “A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible?”Addiction, 95(7):1069-1077 (2000).
Petry et al., “Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens,”Addiction, 96(6):823-834 (2001).
Pfzyborowski et al., “Preparation of HSA Microspheres in a One-Step Thermal Denaturation of Protein Aerosol Carried in Gas-Medium,”Eur. J. Nuc. Med., 7:71-72 (1982).
Shah et al., “A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic)acid (PLGA) copolymers,”J. Controlled Release, 27:139-147 (1993).
Williams et al., “Microencapsulated Local Anesthetics,”Proc. 11thInter. Symp. Control. Rel. Bioactive Mater., pp. 69-70 (1984).

Affiliated with

Also associated with

Rating

High drug loaded injectable microparticle compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High drug loaded injectable microparticle compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High drug loaded injectable microparticle compositions and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3589589